Therapeutic potential of hesperidin in Parkinson’s disease with dementia: inhibition of alpha synuclein and amyloid beta in Drosophila melanogaster
30 Jun 2021-Vol. 36, Iss: 1, pp 43-48
TL;DR: In this article, the authors evaluated the action of hesperidin on α-synuclein and amyloid-β-induced neurodegeneration in Drosophila melanogaster.
Abstract: Parkinson’s disease (PD) and dementia with Lewy bodies have several commonalities including neurochemical, morphological and clinical features as well as widespread of cortical and limbic α-synuclein and amyloid-β pathologies. Thus, we evaluated the action of hesperidin on α-synuclein and amyloid-β-induced neurodegeneration in Drosophila melanogaster. The disease causing human Aβ peptide or α- synuclein was expressed respectively, in Elav-GAL4 (pan-neuronally) and dopaminergic neurons (ddc-GAL4) using the UAS-GAL4 system. Flies were either grown on food media supplemented with or without hesperidin (HSD) (1, 5, or 10mM). Behavioral assays were carried to investigate the effect of treatment on fecundity, larval motility, climbing ability and lifespan. Aβ>Elav or α-syn>DDC caused significant decrease in fecundity, larva contraction, motility, survival rate, and climbing activities in flies indicative of neurodegeneration. However, supplementation of flies’ media with hesperidin (1mM, 5mM and 10mM) showed a dose-dependent increase in the number of line crosses in the egg laying, larva motility, climbing activity in comparison with flies grown on food media only. Conversely, supplementation of fly feed with HSD caused no significant change in lifespan. Findings from this experiment showed that hesperidin could be a potential neuroprotective agent in the amelioration of PD and AD pathogenesis
References
More filters
TL;DR: The GAL4/UAS system in Drosophila is reviewed and the numerous extensions that have morphed it into a veritable Swiss army knife for the analysis of gene function are reviewed.
Abstract: The last decade has seen an enormous expansion in the genetic toolbox of model organisms. This has been particularly apparent in the fruitfly, Drosophila melanogaster, in which the development of these tools and their ongoing extension, along with the completion of the genome sequence has allowed for the analysis of most any process. One particularly elegant example of tool development was the creation of the GAL4/UAS system for targeted gene expression in Drosophila. In addition to helping make Drosophila one of the most genetically tractable metazoans, this system has also helped Drosophila attract attention from the biotechnology industry as a viable means to investigate the function of genes implicated in a wide variety of medically and economically important processes. In this article, we review the GAL4/UAS system in Drosophila and the numerous extensions that have morphed it into a veritable Swiss army knife for the analysis of gene function.
1,162 citations
TL;DR: An overview of the epidemiology of AD is provided, the biomarkers that may be used for risk assessment and in diagnosis are reviewed, and suggestions for future research are given.
940 citations
TL;DR: The discovery of factors in the circulation that have been shown to modulate ageing and to rejuvenate numerous organs, including the brain, is ushering in a new era in ageing and dementia research.
Abstract: Although systemic diseases take the biggest toll on human health and well-being, increasingly, a failing brain is the arbiter of a death preceded by a gradual loss of the essence of being. Ageing, which is fundamental to neurodegeneration and dementia, affects every organ in the body and seems to be encoded partly in a blood-based signature. Indeed, factors in the circulation have been shown to modulate ageing and to rejuvenate numerous organs, including the brain. The discovery of such factors, the identification of their origins and a deeper understanding of their functions is ushering in a new era in ageing and dementia research.
726 citations
TL;DR: The mediators of the underlying cell-death pathways have shown promise as potential therapeutic targets in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Abstract: Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease trigger neuronal cell death through endogenous suicide pathways. Surprisingly, although the cell death itself may occur relatively late in the course of the degenerative process, the mediators of the underlying cell-death pathways have shown promise as potential therapeutic targets.
600 citations
Journal Article•
TL;DR: The nature and extent of the changes associated with neural systems, possible treatment approaches, and a potential mechanism involving chronic neuroinflammation to explain the pattern of neuropathologic changes in Alzheimer's disease are summarized.
Abstract: Alzheimer's disease is characterized by degenerative changes in a variety of neurotransmitter systems. These include alterations in the function of the monoaminergic neural systems that release glutamate, norepinephrine, and serotonin as well as a few neuropeptide-containing systems. Alzheimer's disease is also characterized by degenerative changes in selected brain regions, including the temporal and parietal lobes and restricted regions within the frontal cortex and cingulate gyrus. The degeneration of these systems may underlie specific aspects of the dementia associated with Alzheimer's disease. A major problem in Alzheimer's disease research today is that none of the current hypothesized mechanisms are able to explain the cellular and regional distribution pattern that characterizes the neuropathology of Alzheimer's disease. This article summarizes the nature and extent of the changes associated with neural systems, possible treatment approaches, and a potential mechanism involving chronic neuroinflammation to explain the pattern of neuropathologic changes in Alzheimer's disease.
543 citations